EJNMMI Research

Table 1 Organ absorbed dose per injected activity (Gy/MBq) for 177Lu-m11B6 based on A. ¹¹¹In-m11B6 and B. ¹⁷⁷Lu-m11B6 biokinetics

From: Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2

	A. Based on ¹¹¹In-m11B6		B. Based on ¹⁷⁷Lu-m11B6
Organ	Self-dose	Total dose	Self-dose	Total dose
Tumor	2.2	2.3	4.8	4.9
Submand. gland	1.9	2.0	5.6	5.6
Blood	1.3	1.3	1.2	1.3
Bone marrow	0.40	0.47	0.38	0.45
Liver	0.63	0.66	1.56	1.59
Heart	0.47	0.66	0.56	0.74
Lung	0.41	0.54	0.59	0.71
Spleen	0.67	0.71	1.9	1.9
Kidney	0.50	0.53	0.50	0.54
GI tract	0.30	0.35	0.35	0.44
Bone	0.13	0.27	0.18	0.30
Brain	0.017	0.040	0.019	0.041
Testes	0.24	0.28	0.31	0.35

Back to article page